Coldstream Capital Management Inc Keros Therapeutics, Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
171Shares Held
36.3MCall Options Held
720KPut Options Held
803K-
Nuveen, LLC Charlotte, NC3.95MShares$57.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$37.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.6 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$29.1 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $375M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...